↓ Skip to main content

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

Overview of attention for article published in Radiation Oncology, May 2013
Altmetric Badge

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma
Published in
Radiation Oncology, May 2013
DOI 10.1186/1748-717x-8-130
Pubmed ID
Authors

Ji Zhu, Weilie Gu, Peng Lian, Weiqi Sheng, Gang Cai, Debing Shi, Sanjun Cai, Zhen Zhang

Abstract

Neoadjuvant chemoradiation has become the standard treatment in locally advanced rectal cancer (LARC) and improves local control. This study explored the feasibility of an intensified chemoradiation treatment followed by one cycle of capecitabine before surgery for LARC.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 17%
Unspecified 4 10%
Other 4 10%
Researcher 4 10%
Student > Postgraduate 4 10%
Other 10 24%
Unknown 8 20%
Readers by discipline Count As %
Medicine and Dentistry 19 46%
Unspecified 4 10%
Nursing and Health Professions 3 7%
Computer Science 2 5%
Agricultural and Biological Sciences 2 5%
Other 2 5%
Unknown 9 22%